News

An anti-HIV strategy, called Vectored ImmunoProphylaxis (VIP), MIT and Harvard and Massachusetts General Hospital (MGH) involves using an adeno-associated viral (AAV) vector to deliver instructions to muscle cells to pump out antibodies that block the virus.

Psilocybin’s enduring antidepressant effects may be driven by changes to brain connectivity that free up brain networks, suggests a new study. The proposed mechanism of action may not be shared by traditional SSRI antidepressants.

Research has revealed that the constant pattern of stretching and relaxing caused by breathing generates immune responses against invading viruses.

A variant of the CTLA-4 gene was found to be more frequent in non-small cell lung cancer (NSCLC) patients who experienced an exceptionally high response to anti-PD-1 immunotherapy and higher immune-related side effects than in other lung cancer patients and healthy individuals.

A new study has shown significant metabolic and structural differences in the brains of frontotemporal dementia patients with movement symptoms including tremor.

Researchers have developed a mobile system that can be used at home and aims to promote deep sleep through auditory brain stimulation.

Cell-cell communication between gut bacteria could provide a new target to prevent or treat infections, as new research shows an intracellular signaling mechanism regulates plasmid transfer in the gut.

Researchers have discovered how Gram negative bacteria—which cause numerous drug-resistant infections—finish building a crucial component of their outer membrane that shields them from attacks by the immune system and antibiotics.

A study has shown that mice with a common gene variant associated with ADHD adopt an inattentive phenotype similar to that seen in humans.

An oral medication used to treat pancreatitis improved symptoms in trial participants with newly diagnosed with COVID-19. The drug, camostat mesylate, did little to lessen viral load but did appear to prevent loss of smell or taste.